Regulatory submissions in life science industries are the most critical milestones in a new product development process and the subsequent product lifecycle. A solid submission process can accelerate time to market, bring the benefit of new treatments to patients sooner, maximize research investments, and preserve patient life. But playing at the end of the game brings extra pressure.
Impressive results with Binocs
GSK Vaccines Global Regulatory Affairs (a team of 400+ people) presented their experiences with Binocs resource planning at the Making Pharmaceuticals conference that was held in Brussels on March 14th. Why did GSK GRA implement resource management? Why did GSK GRA choose for Binocs? And......